| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914850 | Molecular Oncology | 2014 | 12 Pages |
Abstract
The study confirms the importance of analyzing prognostic variables separately within BC subtypes, highlights the advantages of using metagenes rather than genes, and finally identifies in node-negative ESR1+/ERBB2â BCs, the unfavorable role of high IFN metagene expression.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Maurizio Callari, Valeria Musella, Eleonora Di Buduo, Marialuisa Sensi, Patrizia Miodini, Matteo Dugo, Rosaria Orlandi, Roberto Agresti, Biagio Paolini, Maria Luisa Carcangiu, Vera Cappelletti, Maria Grazia Daidone,